UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

( R )-(-)-Ketamine: The Promise of a Novel Treatment for Psychiatric and Neurological Disorders

International journal of molecular sciences, 2024-06, Vol.25 (12), p.6804

2024

Volltextzugriff (PDF)

Traumatic brain injury: molecular biomarkers, genetics, secondary consequences, and medical management

Frontiers in neuroscience, 2024-10, Vol.18, p.1446076

2024

Volltextzugriff (PDF)

Understanding and treating moyamoya disease in children

Neurosurgical focus, 2009-04, Vol.26 (4), p.E4-E4

Smith, Jodi L

2009

Volltextzugriff (PDF)

Yield of Skeletal Surveys in Children ≤18 Months of Age Presenting with Isolated Skull Fractures

The Journal of pediatrics, 2013, Vol.162 (1), p.86-89

2013

Volltextzugriff (PDF)

KRM–II–81 suppresses epileptifom activity across the neural network of cortical tissue from a patient with pharmacoresistant epilepsy

Heliyon, 2024-01, Vol.10 (1), p.e23752-e23752, Article e23752

2024

Volltextzugriff (PDF)

Is there a biochemical basis for purinergic P2X3 and P2X4 receptor antagonists to be considered as anti-seizure medications?

Biochemical pharmacology, 2024-04, Vol.222, p.116046, Article 116046

2024

Volltextzugriff (PDF)

Nonsedating anxiolytics

Pharmacology, biochemistry and behavior, 2024-12, Vol.245, p.173895, Article 173895

2024

Volltextzugriff (PDF)

GABAkines – Advances in the discovery, development, and commercialization of positive allosteric modulators of GABAA receptors

Pharmacology & therapeutics (Oxford), 2022-06, Vol.234, p.108035-108035, Article 108035

2022

Volltextzugriff (PDF)

Clinical investigations of compounds targeting metabotropic glutamate receptors

Pharmacology, biochemistry and behavior, 2022-09, Vol.219, p.173446-173446, Article 173446

2022

Volltextzugriff (PDF)

Aberrant neuronal avalanches in cortical tissue removed from juvenile epilepsy patients

Journal of clinical neurophysiology, 2010-12, Vol.27 (6), p.380-386

2010

Volltextzugriff (PDF)

Targeted Blockade of TARP-γ8-Associated AMPA Receptors: Anticonvulsant Activity with the Selective Antagonist LY3130481 (CERC-611)

CNS & neurological disorders drug targets, 2017-12, Vol.16 (10), p.1099-1110

2017

Volltextzugriff (PDF)

In vitro pharmacological and rat pharmacokinetic characterization of LY3020371, a potent and selective mGlu 2/3 receptor antagonist

Neuropharmacology, 2017-03, Vol.115, p.100-114

2017

Volltextzugriff (PDF)

Mortality of adolescents with isolated traumatic brain injury does not vary with type of level I trauma center

The journal of trauma and acute care surgery, 2022-10, Vol.93 (4), p.538-544

2022

Volltextzugriff (PDF)

Where do we go next in antidepressant drug discovery? A new generation of antidepressants: a pivotal role of AMPA receptor potentiation and mGlu2/3 receptor antagonism

Expert opinion on drug discovery, 2022-10, Vol.17 (10), p.1131-1146

2022

Volltextzugriff (PDF)

The imidazodiazepine, KRM-II-81: An example of a newly emerging generation of GABAkines for neurological and psychiatric disorders

Pharmacology, biochemistry and behavior, 2022-02, Vol.213, p.173321-173321, Article 173321

2022

Volltextzugriff (PDF)

Mechanistic and therapeutic relationships of traumatic brain injury and γ-amino-butyric acid (GABA)

Pharmacology & therapeutics (Oxford), 2024-04, Vol.256, p.108609-108609, Article 108609

2024

Volltextzugriff (PDF)

Can GABAkines quiet the noise? The GABA A receptor neurobiology and pharmacology of tinnitus

Biochemical pharmacology, 2022-07, Vol.201, p.115067

2022

Volltextzugriff (PDF)

Can GABAkines quiet the noise? The GABAA receptor neurobiology and pharmacology of tinnitus

Biochemical pharmacology, 2022-07, Vol.201, p.115067-115067, Article 115067

2022

Volltextzugriff (PDF)

Clinical pharmacological innovation in the treatment of depression

Expert review of clinical pharmacology, 2023-04, Vol.16 (4), p.349-362

2023

Volltextzugriff (PDF)

AMPA receptors play an important role in the biological consequences of spinal cord injury: Implications for AMPA receptor modulators for therapeutic benefit

Biochemical pharmacology, 2024-10, Vol.228, p.116302, Article 116302

2024

Volltextzugriff (PDF)

The Positive Allosteric Modulator of α 2/3-Containing GABA A Receptors, KRM-II-81, Is Active in Pharmaco-Resistant Models of Epilepsy and Reduces Hyperexcitability after Traumatic Brain Injury

The Journal of pharmacology and experimental therapeutics, 2020-01, Vol.372 (1), p.83-94

2020

Volltextzugriff (PDF)

Rapid tolerance to behavioral effects of ethanol in rats: Prevention by R-(−)-ketamine

Pharmacology, biochemistry and behavior, 2021-04, Vol.203, p.173152, Article 173152

2021

Volltextzugriff (PDF)

N-Substituted-3-alkoxy-derivatives of dextromethorphan are functional NMDA receptor antagonists in vivo: Evidence from an NMDA-induced seizure model in rats

Pharmacology, biochemistry and behavior, 2021-04, Vol.203, p.173154-173154, Article 173154

2021

Volltextzugriff (PDF)

Letter to the Editor. Standardization of shunt valves: one size does not fit all

Journal of neurosurgery. Pediatrics, 2021-12, Vol.28 (6), p.745-746

2021

Volltextzugriff (PDF)

A Maximum Entropy Model Applied to Spatial and Temporal Correlations from Cortical Networks In Vitro

The Journal of neuroscience, 2008-01, Vol.28 (2), p.505-518

2008

Volltextzugriff (PDF)

1 – 25 von 346

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(321)
Mit Volltextzugriff
(263)

Publikationsform

Sprache

Englisch
(346)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(10)

Menü

Weitere Dienste

Einstellungen

( R )-(-)-Ketamine: The Promise of a Novel Treatment for Psychiatric and Neurological Disorders

Traumatic brain injury: molecular biomarkers, genetics, secondary consequences, and medical management

Understanding and treating moyamoya disease in children

Yield of Skeletal Surveys in Children ≤18 Months of Age Presenting with Isolated Skull Fractures

KRM–II–81 suppresses epileptifom activity across the neural network of cortical tissue from a patient with pharmacoresistant epilepsy

Is there a biochemical basis for purinergic P2X3 and P2X4 receptor antagonists to be considered as anti-seizure medications?

Nonsedating anxiolytics

GABAkines – Advances in the discovery, development, and commercialization of positive allosteric modulators of GABAA receptors

Clinical investigations of compounds targeting metabotropic glutamate receptors

Aberrant neuronal avalanches in cortical tissue removed from juvenile epilepsy patients

Targeted Blockade of TARP-γ8-Associated AMPA Receptors: Anticonvulsant Activity with the Selective Antagonist LY3130481 (CERC-611)

In vitro pharmacological and rat pharmacokinetic characterization of LY3020371, a potent and selective mGlu 2/3 receptor antagonist

Mortality of adolescents with isolated traumatic brain injury does not vary with type of level I trauma center

Where do we go next in antidepressant drug discovery? A new generation of antidepressants: a pivotal role of AMPA receptor potentiation and mGlu2/3 receptor antagonism

The imidazodiazepine, KRM-II-81: An example of a newly emerging generation of GABAkines for neurological and psychiatric disorders

Mechanistic and therapeutic relationships of traumatic brain injury and γ-amino-butyric acid (GABA)

Can GABAkines quiet the noise? The GABA A receptor neurobiology and pharmacology of tinnitus

Can GABAkines quiet the noise? The GABAA receptor neurobiology and pharmacology of tinnitus

Clinical pharmacological innovation in the treatment of depression

AMPA receptors play an important role in the biological consequences of spinal cord injury: Implications for AMPA receptor modulators for therapeutic benefit

The Positive Allosteric Modulator of α 2/3-Containing GABA A Receptors, KRM-II-81, Is Active in Pharmaco-Resistant Models of Epilepsy and Reduces Hyperexcitability after Traumatic Brain Injury

Rapid tolerance to behavioral effects of ethanol in rats: Prevention by R-(−)-ketamine

N-Substituted-3-alkoxy-derivatives of dextromethorphan are functional NMDA receptor antagonists in vivo: Evidence from an NMDA-induced seizure model in rats

Letter to the Editor. Standardization of shunt valves: one size does not fit all

A Maximum Entropy Model Applied to Spatial and Temporal Correlations from Cortical Networks In Vitro

Suchergebnisse filtern